4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-027870
Exec. Director, Finance - PAO sold 445 shares at $10.90 ($4,851)
From the SEC's structured data for this filing
Trades in this filing
Jones Michael L · Exec. Director, Finance - PAO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-15 | Sale : show line 1 in the form | −445 | $10.90 | $4,851 | 10,753 | D |
| Open-market sales · 445 sh · avg $10.90 · $4,851 | ||||||
Loading xslF345X03/form4.xml…